Episode Details
Back to EpisodesBeyond Implants: How Conexeu’s ($CNXU) B.R.E.A.S.T.™ Could Advance Tissue Regeneration
Description
This interview is disseminated on behalf of Conexeu Sciences Inc.
Reconstruction is being redefined with Conexeu Sciences Inc. (NASDAQ: CNXU), as the company recently announced the development of Bio-Regenerative Ergonomically Architected Smart Tissue™ (B.R.E.A.S.T.™), a new approach designed to advance breast reconstruction following mastectomy.
In this exclusive interview, Chief Scientific Officer and Co-Founder Dr. Claudia Chavez-Munoz, MD, PhD, outlines the science behind the program, its mechanism of action, and how the company is leveraging its proprietary CXU™ platform to expand across multiple applications.
Watch now to find out how B.R.E.A.S.T.™ is designed to potentially help the body rebuild itself.
Learn more: https://www.conexeu.com/
Watch the full YouTube interview here: https://youtu.be/N8thuQMx6Z8
And follow us to stay updated: https://www.youtube.com/GlobalOneMedia